RecruitingNCT06261034

A Study of Sex Differences in Neurocirculatory Control

Sex Differences in Neurocirculatory Control With Obstructive Sleep Apnea

Sponsor

Mayo Clinic

Enrollment

60 participants

Start Date

Oct 29, 2024

Study Type

OBSERVATIONAL

Conditions

Obstructive Sleep Apnea

Summary

The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA).

Eligibility

Min Age: 20 YearsMax Age: 70 Years

Inclusion Criteria1

-70 years of age

Exclusion Criteria13

Coronary artery disease
Heart failure
Pregnancy
COPD
Diabetes
CKD
Sleep disorders other than OSA
Shift workers
Individuals who typically go to sleep after midnight
Individuals who traveled across ≥2 time zones within one week of study visits
BMI ≥40.0kg/m2
Use of nicotine-containing products within the two years preceding study visits
Use of allopurinol, proton pump inhibitors, or other medications/supplements which interfere with outcome measures

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06261034

Related Trials

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

NCT0722676538 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

NCT0722568647 locations